Aller au contenu principal
Accès ouvert déclaré 2025 article

Emblica officinalis (Amla): An Ayurvedic Legacy with Modern Therapeutic Promise

0Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Le résumé fourni par la source

Emblica officinalis, commonly known as Indian gooseberry or amla, holds a distinguished place in traditional healing systems such as Ayurveda, Siddha, and Unani. Celebrated as a rejuvenating “Rasayana” in Ayurvedic medicine, amla is revered for its remarkable nutritional and therapeutic attributes. The fruit is especially rich in vitamin C and a diverse array of bioactive compounds, including flavonoids, tannins, alkaloids, and phenolic substances, which contribute to its extensive pharmacological profile. Modern scientific investigations have validated many of its traditional uses, highlighting its potent antioxidant, anti-inflammatory, antimicrobial, antidiabetic, cardioprotective, hepatoprotective, and neuroprotective activities. These properties position E. officinalis as a promising natural agent for the prevention and management of chronic conditions such as diabetes, cardiovascular diseases, neurodegenerative disorders, and cancer. Traditionally, amla has been employed to enhance digestion, respiratory health, immunity, and overall vitality. Its adaptogenic and immunomodulatory effects are particularly noteworthy in the context of holistic health management. With a strong safety profile and centuries of documented use, amla continues to attract global interest as a valuable component of functional foods, dietary supplements, and novel therapeutic formulations. This review aims to provide a comprehensive overview of Emblica officinalis with emphasis on its Ayurvedic heritage, phytochemical richness, and pharmacological relevance, thereby bridging traditional knowledge with contemporary biomedical research.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Emblica officinalis (Amla): An Ayurvedic Legacy with Modern Therapeutic Promise
Date Crossref
01/07/2025
Éditeur
Comprehensive Publications
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les sujets associés

Phytochemicals and Medicinal PlantsBotanical Research and ChemistryFood Science and Nutritional Studies

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.